{"id":"autologous-cord-blood-cell-therapy","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fever"},{"rate":"5-10%","effect":"Infection"},{"rate":"5-10%","effect":"Bleeding"}]},"_chembl":{"chemblId":"CHEMBL4594461","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This treatment works by introducing stem cells from the patient's own cord blood into the affected area, where they can differentiate into various cell types and promote tissue regeneration. The exact mechanisms of action are not fully understood, but it is thought to involve the release of growth factors and other signaling molecules that stimulate cellular repair and regeneration.","oneSentence":"Autologous cord blood cell therapy involves using a patient's own cord blood cells to stimulate healing and repair in damaged tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:29:47.808Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of neonatal encephalopathy"}]},"trialDetails":[{"nctId":"NCT06345495","phase":"PHASE2","title":"High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-10-01","conditions":"Splenomegaly, Myelofibrosis","enrollment":30},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT06207799","phase":"PHASE2","title":"Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-07-17","conditions":"Multiple Myeloma, Post-transplant MRD-guided Maintenance Therapy, Pre-transplant Purging","enrollment":40},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT07253233","phase":"EARLY_PHASE1","title":"Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors","status":"NOT_YET_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-12-01","conditions":"Spinal Cord Injury","enrollment":10},{"nctId":"NCT03779711","phase":"PHASE2","title":"Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2019-06-06","conditions":"Hypoplastic Left Heart Syndrome","enrollment":95},{"nctId":"NCT02722668","phase":"PHASE2","title":"UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-05-15","conditions":"Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma","enrollment":15},{"nctId":"NCT04907526","phase":"PHASE1","title":"Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2021-06-01","conditions":"Congenital Heart Disease, SRV Dependent","enrollment":30},{"nctId":"NCT07021534","phase":"PHASE1","title":"Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2025-06-10","conditions":"Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments","enrollment":12},{"nctId":"NCT06995274","phase":"NA","title":"Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study","status":"NOT_YET_RECRUITING","sponsor":"Bundang CHA Hospital","startDate":"2025-06-01","conditions":"Autism Spectrum Disorder, Eosinophilic Gastrointestinal Disorders","enrollment":1},{"nctId":"NCT01729091","phase":"PHASE2","title":"Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-06-10","conditions":"Plasma Cell Leukemia, Plasma Cell Myeloma","enrollment":72},{"nctId":"NCT06896747","phase":"PHASE1, PHASE2","title":"Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-02-21","conditions":"Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions","enrollment":90},{"nctId":"NCT02881970","phase":"PHASE1, PHASE2","title":"Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2020-02-05","conditions":"Neonatal Hypoxic-ischaemic Encephalopathy","enrollment":20},{"nctId":"NCT00593242","phase":"PHASE1","title":"Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy","status":"COMPLETED","sponsor":"Michael Cotten","startDate":"2008-01","conditions":"Neonatal Hypoxic Ischemic Encephalopathy","enrollment":52},{"nctId":"NCT01700166","phase":"PHASE1","title":"Umbilical Cord Blood in the Treatment of Stroke in Children.","status":"WITHDRAWN","sponsor":"Aryn Knight","startDate":"2012-09","conditions":"Arterial Ischemic Stroke (AIS) in Children","enrollment":""},{"nctId":"NCT01343394","phase":"PHASE1","title":"Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children","status":"WITHDRAWN","sponsor":"Aryn Knight","startDate":"2011-04","conditions":"Hearing Loss","enrollment":""},{"nctId":"NCT02551003","phase":"PHASE1, PHASE2","title":"Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy","status":"WITHDRAWN","sponsor":"Children's Hospital of Fudan University","startDate":"2015-09-08","conditions":"Hypoxic Ischemic Encephalopathy, Cerebral Infarction","enrollment":""},{"nctId":"NCT03019640","phase":"PHASE2","title":"Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-10","conditions":"Mantle Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma","enrollment":22},{"nctId":"NCT01988584","phase":"PHASE2","title":"Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-11","conditions":"Cerebral Palsy","enrollment":20},{"nctId":"NCT01072370","phase":"PHASE1, PHASE2","title":"Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children","status":"WITHDRAWN","sponsor":"Augusta University","startDate":"2010-01","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT03431480","phase":"PHASE1","title":"Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2018-02-16","conditions":"Hypoplastic Left Heart Syndrome, Heart Defects, Congenital, Pediatric Disorder","enrollment":10},{"nctId":"NCT01883076","phase":"PHASE1","title":"Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome","status":"COMPLETED","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2013-05-15","conditions":"Hypoplastic Left Heart Syndrome","enrollment":30},{"nctId":"NCT05138276","phase":"EARLY_PHASE1","title":"Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2021-09-01","conditions":"Neonatal Necrotizing Enterocolitis, Growth and Development, Preterm Infants","enrollment":60},{"nctId":"NCT02999373","phase":"PHASE2","title":"Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2018-07-01","conditions":"Bronchopulmonary Dysplasia, Premature, Neonatal Death","enrollment":62},{"nctId":"NCT05071638","phase":"PHASE3","title":"Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2021-10-01","conditions":"BPD","enrollment":76},{"nctId":"NCT04710810","phase":"PHASE1","title":"UCB Stem Cells for Autism Spectrum Disorders","status":"COMPLETED","sponsor":"St. Petersburg Bekhterev Research Psychoneurological Institute","startDate":"2019-11-04","conditions":"Autism Spectrum Disorder","enrollment":30},{"nctId":"NCT04768816","phase":"PHASE1","title":"Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2019-07-01","conditions":"Safety Issues;Effect of Drugs","enrollment":25},{"nctId":"NCT04243382","phase":"PHASE2","title":"Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-02-27","conditions":"Autistic Spectrum Disorder","enrollment":60},{"nctId":"NCT00305682","phase":"PHASE2","title":"Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-06","conditions":"Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":295},{"nctId":"NCT04501341","phase":"PHASE1, PHASE2","title":"BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2016-03-14","conditions":"T2D","enrollment":15},{"nctId":"NCT00345865","phase":"PHASE2","title":"Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-08-24","conditions":"Lymphoma","enrollment":473},{"nctId":"NCT02847182","phase":"PHASE2","title":"Cord Blood Infusion for Children With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Joanne Kurtzberg, MD","startDate":"2016-09","conditions":"Autism Spectrum Disorder, ASD, Autism","enrollment":180},{"nctId":"NCT04311476","phase":"PHASE2","title":"Autologous Cord Blood Cells for Prevention of BPD in Preterm","status":"COMPLETED","sponsor":"yangjie","startDate":"2018-07-01","conditions":"Safety Issues, BPD - Bronchopulmonary Dysplasia, Neonatal Death","enrollment":62},{"nctId":"NCT03760900","phase":"EARLY_PHASE1","title":"Safety of Autologous Cord Blood Cells for Preterm Infants.","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2009-01-01","conditions":"Safety Issues, Effect of Drugs, Neonatal Death","enrollment":15},{"nctId":"NCT03203941","phase":"","title":"ACT for CP Individual Patient Expanded Access IND Protocol","status":"NO_LONGER_AVAILABLE","sponsor":"Charles Cox","startDate":"","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT03579927","phase":"PHASE1, PHASE2","title":"CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-10-03","conditions":"CD19 Positive, Mantle Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":""},{"nctId":"NCT00018018","phase":"PHASE1","title":"Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency","status":"COMPLETED","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2001-06-20","conditions":"Severe Combined Immunodeficiency Syndrome","enrollment":8},{"nctId":"NCT02455830","phase":"","title":"Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy","status":"UNKNOWN","sponsor":"Neonatal Encephalopathy Consortium, Japan","startDate":"2015-04","conditions":"Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)","enrollment":18},{"nctId":"NCT02256618","phase":"PHASE1","title":"Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy","status":"COMPLETED","sponsor":"Neonatal Encephalopathy Consortium, Japan","startDate":"2014-08","conditions":"Neonatal Encephalopathy, Hypoxic-ischemic Encephalopathy","enrollment":6},{"nctId":"NCT00568633","phase":"PHASE3","title":"Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML","status":"TERMINATED","sponsor":"Stanford University","startDate":"2007-08","conditions":"Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML)","enrollment":58},{"nctId":"NCT00802113","phase":"PHASE1, PHASE2","title":"Autologous and Allogeneic Transplant for Relapsed Lymphoma","status":"COMPLETED","sponsor":"Columbia University","startDate":"2003-06","conditions":"Non-Hodgkin's Lymphoma, Hodgkins Disease","enrollment":30},{"nctId":"NCT03881774","phase":"PHASE1","title":"Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2019-02-27","conditions":"Refractory, Relapsed, B Cell Lymphoma","enrollment":20},{"nctId":"NCT03791372","phase":"PHASE1","title":"Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2017-10-10","conditions":"Safety Issues, Effect of Drugs","enrollment":25},{"nctId":"NCT03696745","phase":"PHASE1","title":"The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2018-11-01","conditions":"Safety Issues, Effect of Drugs","enrollment":200},{"nctId":"NCT03352310","phase":"PHASE1","title":"Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia","status":"UNKNOWN","sponsor":"Mononuclear Therapeutics Ltd.","startDate":"2018-04-16","conditions":"Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal, Cerebral Ischemia of Newborn","enrollment":40},{"nctId":"NCT02038972","phase":"PHASE1, PHASE2","title":"Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss","status":"COMPLETED","sponsor":"James Baumgartner, MD","startDate":"2013-01","conditions":"Sensorineural Hearing Loss","enrollment":11},{"nctId":"NCT01769716","phase":"NA","title":"Umbilical Cord Blood Therapy for Global Developmental Delay","status":"COMPLETED","sponsor":"MinYoung Kim, M.D.","startDate":"2012-12","conditions":"Global Developmental Delay","enrollment":14},{"nctId":"NCT01343368","phase":"PHASE2","title":"Preservation of Ovarian Function After Hematopoietic Cell Transplant","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2011-07","conditions":"Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease","enrollment":19},{"nctId":"NCT02022696","phase":"PHASE1","title":"Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector","status":"COMPLETED","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2013-12-16","conditions":"Adenosine Deaminase Deficiency, ADA-SCID","enrollment":1},{"nctId":"NCT00719849","phase":"PHASE2","title":"Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2005-11","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":13},{"nctId":"NCT03053076","phase":"PHASE1","title":"Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2017-02-10","conditions":"Safety Issues, Effect of Drugs, Neonatal Death","enrollment":200},{"nctId":"NCT02749448","phase":"PHASE1","title":"Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients","status":"UNKNOWN","sponsor":"Dr. Mostafa Ghanei","startDate":"2015-02","conditions":"Pulmonary Disease","enrollment":10},{"nctId":"NCT01251003","phase":"PHASE1, PHASE2","title":"Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury","status":"WITHDRAWN","sponsor":"Charles Cox","startDate":"2011-01","conditions":"Traumatic Brain Injury","enrollment":""},{"nctId":"NCT00873925","phase":"PHASE1","title":"Cord Blood Plus Vitamin D and Omega 3s in T1D","status":"COMPLETED","sponsor":"University of Florida","startDate":"2009-03","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT01763099","phase":"PHASE2","title":"Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2013-01","conditions":"Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cells, Umbilical Cord Blood","enrollment":60},{"nctId":"NCT01355549","phase":"PHASE1","title":"Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury","status":"COMPLETED","sponsor":"Kessler Foundation","startDate":"2011-05","conditions":"Shoulder Pain, Rotator Cuff Tendinitis, Rotator Cuff Syndrome","enrollment":6},{"nctId":"NCT01673789","phase":"PHASE1, PHASE2","title":"Stem Cell Educator Therapy in Alopecia Areata","status":"UNKNOWN","sponsor":"Throne Biotechnologies Inc.","startDate":"2012-08","conditions":"Alopecia Areata","enrollment":30},{"nctId":"NCT01523769","phase":"NA","title":"Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2009-09","conditions":"Prematurity","enrollment":113},{"nctId":"NCT00001255","phase":"","title":"Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study","status":"COMPLETED","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"1990-09","conditions":"Severe Combined Immunodeficiency","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Autologous cord blood cell therapy","genericName":"Autologous cord blood cell therapy","companyName":"Neonatal Encephalopathy Consortium, Japan","companyId":"neonatal-encephalopathy-consortium-japan","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous cord blood cell therapy involves using a patient's own cord blood cells to stimulate healing and repair in damaged tissues. Used for Treatment of neonatal encephalopathy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}